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Medulloblastoma is the most common malignant brain tumor in children, but the cells from which it arises
remain unclear. Here we examine the origin of medulloblastoma resulting frommutations in the Sonic hedge-
hog (Shh) pathway. We show that activation of Shh signaling in neuronal progenitors causes medulloblas-
toma by 3 months of age. Shh pathway activation in stem cells promotes stem cell proliferation but only
causes tumors after commitment to—and expansion of—the neuronal lineage. Notably, tumors initiated in
stem cells develop more rapidly than those initiated in progenitors, with all animals succumbing by 3–4
weeks. These studies suggest that medulloblastoma can be initiated in progenitors or stem cells but that
Shh-induced tumorigenesis is associated with neuronal lineage commitment.INTRODUCTION
The cell of origin for most types of cancer remains unknown.
Identifying the normal cell that gives rise to a tumor is important
because it allows studies of the normal cell to be used as
a source of insight into the behavior of the tumor. Moreover, it al-
lows for direct comparisons between tumor cells and their nor-
mal counterparts (e.g., using genomic or proteomic approaches)
so that key differences and vulnerabilities of tumor cells can be
identified. Finally, recent studies suggest that cells resembling
the cell of origin may persist in mature tumors and may be critical
for propagating these tumors in vivo. If so, identifying the cell of
origin may facilitate development of more effective approaches
to therapy.Our studies have focused on the cell of origin for medulloblas-
toma, a highly malignant tumor of the cerebellum. Medulloblas-
toma occurs most frequently in children between the ages of 5
and 10 but may occur in adults as well (Ellison, 2002; Packer
et al., 1999). Despite important progress in treatment of the dis-
ease, the prognosis for many medulloblastoma patients remains
bleak: almost half of the patients who develop the disease die
from it, and those who survive often suffer severe side effects
from the treatment, including cognitive deficits, endocrine disor-
ders, and increased susceptibility to secondary tumors later in
life (Heikens et al., 1998; Mulhern et al., 2005; Packer et al.,
1999). Improved approaches for treating medulloblastoma are
likely to result from a deeper understanding of its molecular
and cellular origins.SIGNIFICANCE
The Sonic hedgehog (Shh) pathway regulates growth of neural progenitors and stem cells, and activation of this pathway
has been suggested to play a role in medulloblastoma and other brain tumors. We use conditional Patched knockout
mice to test the effects of Shh pathway activation in granule neuron precursors and stem cells. We demonstrate that
both cell types can serve as cells of origin for medulloblastoma and that the cell in which the tumor is initiated can have
an important impact on the rate of tumor progression. Moreover, we show that deletion of Patched in stem cells leads to
medulloblastoma and not astrocytoma or oligodendroglioma, suggesting that the neuronal lineage may provide a critical
context for the oncogenic effects of Shh signaling.Cancer Cell 14, 135–145, August 12, 2008 ª2008 Elsevier Inc. 135
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Cell of Origin for Ptc-Associated MedulloblastomaThe cell of origin for medulloblastoma has been the subject of
debate for many years (Eberhart, 2007; Read et al., 2006). The
morphology of tumor cells and their location on the surface of
the cerebellum have led to speculation that the tumors arise
from granule neuron precursors (GNPs), restricted progenitors
that give rise only to granule neurons. In support of this view, im-
munohistochemical studies have demonstrated that medullo-
blastoma cells express markers commonly associated with
GNPs, such as p75NTR, TrkC, Zic1, and Math1 (Buhren et al.,
2000; Pomeroy et al., 1997; Salsano et al., 2004; Yokota et al.,
1996). On the other hand, a variety of studies have shown that
medulloblastomas can express stem cell markers and can differ-
entiate into both neurons and glia (Hemmati et al., 2003; Singh
et al., 2003), raising the possibility that these tumors may arise
from multipotent neural stem cells (NSCs). More recently, it
has been suggested that some subtypes of medulloblastoma
may arise from stem cells and others from GNPs (Gilbertson
and Ellison, 2008); however, definitive evidence for the cell of
origin of any particular subtype of medulloblastoma remains
elusive.
Although analysis of markers expressed by human medullo-
blastoma cells can provide clues to the cell of origin, such stud-
ies have significant limitations. In part, this is because the early
stages of tumorigenesis are usually not detectable or accessible
in human patients, so inferences about the cell of origin must be
made retrospectively based on the phenotype of cells from fully
formed tumors. Since these cells may have changed dramati-
cally during the course of tumorigenesis, expression of a particu-
lar marker in a tumor cell may not reflect the expression of this
marker during development. In these respects, mouse models
of medulloblastoma offer significant advantages for studying
the origin of the disease.
One of the most powerful and widely studied models of medul-
loblastoma is the Patched (Ptc) mutant mouse (Goodrich et al.,
1997; Oliver et al., 2005).Ptc is an antagonist of the Sonic hedge-
hog (Shh) signaling pathway, which functions as a critical regula-
tor of both stem cells and progenitors in the central nervous
system (Ahn and Joyner, 2005; Balordi and Fishell, 2007; Wechs-
ler-Reya and Scott, 1999). Homozygous Ptc knockouts have
multiple defects in the neural tube, heart, and other tissues and
die early in embryogenesis (Goodrich et al., 1997). Heterozy-
gotes from this strain survive, and approximately 15% of them
develop cerebellar tumors that resemble human medulloblas-
toma (Goodrich et al., 1997; Oliver et al., 2005). Since Ptc muta-
tions have also been observed in many human medulloblasto-
mas (Hahn et al., 1996; Johnson et al., 1996; Raffel et al.,
1997), these animals have become an important model for the
disease. Studies of Ptc mutant mice have provided insight into
the early stages of tumorigenesis (Oliver et al., 2005), interactions
between Ptc and other tumor suppressor genes (Hahn et al.,
2000; Wetmore et al., 2001; Zindy et al., 2007), and the utility
of hedgehog pathway inhibitors as therapeutic agents for medul-
loblastoma (Romer et al., 2004; Sanchez and Ruiz i Altaba, 2005).
However, because Ptc is mutated in all cells in these animals (in-
cluding NSCs and GNPs), they cannot be readily used to study
the cell of origin.
To identify the cell of origin for Ptc-associated medulloblas-
toma, we have taken advantage of a conditional allele of Ptc
(Adolphe et al., 2006; Ellis et al., 2003) that allows inactivation136 Cancer Cell 14, 135–145, August 12, 2008 ª2008 Elsevier Inc.of the gene in either GNPs or NSCs. We show that deletion of
Ptc in GNPs results in a marked expansion of the external germi-
nal layer (EGL) where granule cells develop. Although many Ptc-
deficient GNPs eventually stop dividing and differentiate into
neurons, in each animal a cohort of GNPs continues to prolifer-
ate, and by 3 months of age, all mice develop tumors. Deletion
of Ptc in multipotent stem cells leads to expansion of the stem
cell population, but only stem cells that commit to the granule
lineage continue to divide and go on to form tumors. The in-
creased production of GNPs (from the expanded stem cell
pool) and the continued growth of these cells during postnatal
development leads to rapid tumor formation, with 100% of ani-
mals succumbing to medulloblastoma by 3–4 weeks of age.
These studies demonstrate that both progenitors and stem cells
can respond to Shh signaling and can serve as cells of origin for
medulloblastoma.
RESULTS
Math1-cre/PtcC/C Mice Allow Deletion of Ptc in GNPs
Mice heterozygous for mutations in Ptc develop cerebellar tu-
mors that resemble human medulloblastoma (Goodrich et al.,
1997; Oliver et al., 2005). In these mice, Ptc is inactivated in all
cells (including GNPs and NSCs), so definitive conclusions about
the cell of origin are not possible. To determine whether loss of
Ptc in GNPs can lead to medulloblastoma, we sought to create
GNP-specific Ptc knockout mice. To this end, we crossed two
strains of mice: Math1-cre transgenic mice (Schu¨ller et al.,
2007), which express Cre recombinase specifically in GNPs,
and conditional Ptc knockout (PtcC/C) mice (Adolphe et al.,
2006; Ellis et al., 2003), which have loxP recombinase recogni-
tion sites flanking a portion of the Ptc gene.
Math1-cre mice were generated using a construct containing
the Cre coding sequence downstream of a 1.4 kb Math1 en-
hancer element that has been used previously to express trans-
genes in GNPs (Machold and Fishell, 2005). To examine expres-
sion of Cre protein in these mice, we stained embryonic and
postnatal tissues with anti-Cre antibodies (see Figure S1 avail-
able online). Consistent with previous studies (Machold and
Fishell, 2005; Wang et al., 2005), we found that the Cre protein
was first expressed by rhombic lip-derived cells that are des-
tined to leave the cerebellum and give rise to neurons of the
deep cerebellar nuclei (DCN) and brainstem (Figure S1A) (Mac-
hold and Fishell, 2005). By embryonic day 14.5 (E14.5), Cre
was expressed by GNPs in the EGL (Figures S1B–S1D). Cre ex-
pression persisted in the EGL for the first 2–3 weeks after birth
(Figure S1E); by adulthood, when all GNPs had differentiated
into granule neurons and migrated into the internal granule layer
(IGL), Cre expression was no longer detectable in the cerebellum
(Figure S1F).
To determine whether Cre activity correlated with Cre protein
expression, we crossed Math1-cre mice with ROSA26 reporter
(R26R) mice expressing green fluorescent protein (GFP) pre-
ceded by a loxP-flanked stop sequence (Mao et al., 2001). As
shown in Figure 1A, neonatal Math1-cre/R26R-GFP mice ex-
pressed high levels of GFP in the cerebellum. Analysis of postna-
tal cerebellar sections (Figure 1B) revealed GFP expression only
in proliferating GNPs in the outer EGL (Ki67+ cells in Figure 1C)
and in postmitotic granule cells in the inner EGL and IGL
Cancer Cell
Cell of Origin for Ptc-Associated MedulloblastomaFigure 1. Conditional Knockout Mice Allow
GNP-Specific Deletion of Ptc and Activation
of the Hedgehog Pathway
(A) Brain from P8 Math1-cre/R26R-GFP mouse
shows Cre-induced GFP expression in the cere-
bellum.
(B) Cerebellar section shows GFP in the external
and internal granule layers (EGL and IGL), but not
in the molecular layer (ML) or white matter (WM).
(C and D) Within the EGL and IGL, GFP colocalizes
with proliferating (Ki67+) GNPs and postmitotic
(NeuN+) GNPs and granule neurons (yellow stain-
ing).
(E–H) No GFP is detected in calbindin+ Purkinje
cells (pc) (E), Pax2+ interneuron progenitors (F),
BLBP+ Bergmann glia (bg) and astrocytes (G), or
O4+ oligodendrocytes in the WM (H).
(I and J) GNPs from neonatal PtcC/C mice were in-
fected with no virus () or with viruses carrying
GFP or cre-IRES-GFP. Infected (GFP+) cells
were FACS sorted, and mRNA was analyzed by
conventional RT-PCR (I) to detect Ptc and b2-mi-
croglobulin (b2M) or by real-time RT-PCR (J) to
detect expression of the hedgehog target genes
Gli1, Cyclin D1, and N-myc.
(K) Cells infected with the indicated viruses were cultured for 48 hr before being pulsed with tritiated thymidine (3H-Td), cultured for an additional 18 hr, and
harvested to measure thymidine incorporation. Data represent means of triplicate samples ± SEM.
Scale bars: 3 mm in (A); 25 mm in (B)–(H).(NeuN+ cells in Figure 1D). GFP could also be detected in rhom-
bic lip-derived cells that had left the cerebellum and settled in the
DCN and brain stem (Figure S2). No GFP was seen in other cell
types in the cerebellar cortex, including Purkinje neurons, basket
and stellate neurons, Bergmann glia, and oligodendrocytes (Fig-
ures 1E–1H). By postnatal day 21 (P21), greater than 95% of
NeuN+ cells expressed GFP (Figure S3A), indicating that the ma-
jority of granule cells had been exposed to Cre during develop-
ment. Thus, Math1-cre mice can be used to delete loxP-flanked
genes in GNPs.
To test the effects of loss of Ptc on GNPs, we isolated cells
from the cerebellum of neonatal PtcC/C mice, infected them
with Cre-encoding retroviruses, and analyzed expression of
Ptc and hedgehog target genes by RT-PCR. As shown in
Figure 1I, cells infected with cre viruses showed no detectable
Ptc expression. Since Ptc is a negative regulator of the hedge-
hog pathway (Goodrich et al., 1996), its loss should result in
Shh pathway activation. Consistent with this, cre retrovirus-me-
diated deletion of Ptc resulted in increased expression of Gli1,
Cyclin D1 (Ccnd1), and N-myc, all previously identified as Shh
target genes in GNPs (Kenney et al., 2003; Oliver et al., 2003)
(Figure 1J). Finally, Shh pathway activation has been demon-
strated to promote proliferation of GNPs (Wechsler-Reya and
Scott, 1999); Figure 1K shows that cells infected with cre viruses
show extensive proliferation compared to cells infected with
control viruses. Thus, deletion of Ptc in GNPs promotes Shh
pathway activation and proliferation.
Deletion of Ptc in GNPs Promotes Proliferation but Does
Not Prevent Differentiation
We next tested the effects of GNP-specific Ptc deletion in vivo by
crossing PtcC/C mice with Math1-cre mice. The efficiency of Ptc
deletion in these mice was examined by laser capturing EGLcells from Math1-cre/PtcC/C cerebella and analyzing their DNA
by quantitative PCR; this analysis revealed a >90% reduction
in Ptc compared to EGL cells from wild-type (WT) mice (Figures
S3C and S3D). We then examined the structure of the cerebel-
lum in these animals at various stages of development. At E15,
Math1-cre/PtcC/C mice were indistinguishable from WT litter-
mates and showed no significant changes in cerebellar architec-
ture (data not shown). However, after birth (P1–P8), Math1-cre/
PtcC/C animals exhibited a dramatic thickening of the EGL
(Figures 2E and 2F) compared to WT littermates (Figures 2A
and 2B). By P21, all GNPs in WT mice had differentiated and
migrated into the IGL, and there was no EGL remaining
(Figure 2D). At this stage, the cerebellum of Math1-cre/PtcC/C
mice was significantly larger than that of WT littermates (Figures
2C and 2G) and still contained a thick EGL (Figure 2H). These
data indicate that deletion of Ptc in GNPs leads to severe cere-
bellar hyperplasia.
Animals with defects in granule cell development often display
ataxia or other behavioral abnormalities (Hamre and Goldowitz,
1997; Surmeier et al., 1996). However, at 4–6 weeks of age,
most Math1-cre/PtcC/C mice displayed normal behavior, sug-
gesting that at least some normal granule neurons were gener-
ated in these animals. To determine whether this was the case,
we analyzed the cerebellum of Math1-cre/PtcC/C mice at 6
weeks. In contrast to WT cerebellum (Figures 3A and 3D), the
Math1-cre/PtcC/C cerebellum still contained a thick layer of pro-
liferating GNPs on its surface (Figures 3B and 3E). However, be-
neath this proliferative zone, the normal organization of the cer-
ebellum was maintained, with a distinct Purkinje cell layer
surrounding a layer of mature granule neurons that expressed
normal differentiation markers (Figure 3E; Figure S4). Deletion
of Ptc in mature granule cells was confirmed by RT-PCR analysis
after laser-capture microdissection (Figures 3G–3I). SomeCancer Cell 14, 135–145, August 12, 2008 ª2008 Elsevier Inc. 137
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Cell of Origin for Ptc-Associated MedulloblastomaFigure 2. Deletion of Ptc in GNPs Leads to Severe Hyperplasia
Math1-cre mice were crossed with PtcC/C mice, and brains of wild-type (WT) or mutant progeny were harvested at the indicated ages. Brains were fixed and
photographed intact (C and G) or sectioned and stained with hematoxylin and eosin (H&E) (A, B, D–F, and H). Note the enlargement of the cerebellum and severe
hyperplasia on the surface at P8 and P21. Scale bars: 30 mm in (A), (B), (E), and (F); 2.5 mm in (C) and (G); 400 mm in (D) and (H).regions of the Math1-cre/PtcC/C cerebellum were more disrup-
ted, showing a nodular structure rather than discrete layers of
cells (Figures 3C and 3F). However, even in these regions there
Figure 3. MostMath1-cre/PtcC/CGNPs Differentiate despite Loss of
Ptc
(A–F) Cerebella from 6-week-old WT (A and D) and Math1-cre/PtcC/C (B, C, E,
and F) mice were stained with H&E (A–C) or with anti-Ki67 (green) to detect
proliferation and anti-GABRA6 (red) to detect granule neuron differentiation
(D–F). Whereas WT cerebella contain no proliferating cells (A and D), mutants
exhibit extensive proliferation and differentiation, with proliferating cells either
localized to the surface (B and E) or in nodules surrounded by differentiated
cells (C and F).
(G and H) Cerebellar sections from 6-week-old WT (G) and Math1-cre/PtcC/C
(H) mice were stained with cresyl violet, and the regions indicated by arrows
were laser captured for RNA analysis.
(I) RNA from WT IGL (lane 1, derived from region 1 in [G]),Math1-cre/PtcC/C IGL
(lane 2, from region 2 in [H]), WT EGL (lane 3, tissue not shown), and prolifer-
ating cells at the surface of Math1-cre/PtcC/C cerebellum (lane 4, from region
4 in [H]) were analyzed by RT-PCR for expression of Ptc and b2-microglobulin
(b2M). Note the lack of Ptc expression in mutant IGL (lane 2).
Scale bars: 300 mm in (A)–(C); 30 mm in (D)–(H).138 Cancer Cell 14, 135–145, August 12, 2008 ª2008 Elsevier Inc.was a remarkable conservation of granule cell organization and
differentiation, with each nodule containing a core of proliferating
GNPs surrounded by a molecular layer, a Purkinje cell layer, and
a ring of differentiated granule cells that resembled an IGL (Fig-
ure 3F; Figure S4B). These observations suggest that loss of
Ptc in GNPs results in prolonged proliferation but that many
Ptc-deficient cells are still able to exit the cell cycle and differen-
tiate into mature neurons.
Deletion of Ptc in GNPs Results in Medulloblastoma
Although Math1-cre/PtcC/C mice were asymptomatic in early
adulthood, by 8 weeks of age many animals began to display
signs of illness, including domed head, hunched back, abnormal
gait, and/or decreased movement. By 10–11 weeks, all Math1-
cre/PtcC/C mice became severely ill and had to be sacrificed
(Figure 4F). Upon gross examination, the cerebellum from these
animals appeared enlarged and covered with blood vessels
(Figure 4A). Histological analysis revealed massive tumors that
pervaded the cerebellum and obliterated the normal architecture
that was present earlier in development (Figure 4B). The tumors
could be propagated by transplantation into immunodeficient
hosts, indicating that they represented fully transformed tumor
cells (Figure 4C). These data suggest that deletion of Ptc in
Math1-expressing cells, while not sufficient to transform every
cell, is sufficient to cause tumors in every mouse.
Although Math1 expression is specific to GNPs in the postna-
tal cerebellum, during embryonic development the Math1 en-
hancer is also expressed in progenitors that end up leaving the
cerebellar cortex and migrating to the DCN and brainstem (Mac-
hold and Fishell, 2005; Wang et al., 2005) (Figure S2). To deter-
mine whether the tumors in Math1-cre/PtcC/C mice could have
originated from these progenitors, we crossed PtcC/C mice
with Math1-creER transgenic mice (Machold and Fishell, 2005),
which express a Cre recombinase-estrogen receptor fusion pro-
tein that can be activated by tamoxifen. When Math1-creER/
PtcC/C mice were treated with tamoxifen at E10.5—a stage
when Math1 is only expressed by DCN and brainstem progeni-
tors—none of the animals (0/8 mice) developed tumors (Table
S1). In contrast, when mice were treated with tamoxifen at
E14.5, when Math1 is expressed in GNPs, 100% of the animals
Cancer Cell
Cell of Origin for Ptc-Associated Medulloblastoma(7/7) developed tumors. These data suggest that tumors in
Math1-cre/PtcC/C mice are derived from GNPs.
GNPs are present in mice until 2–3 weeks after birth. To deter-
mine whether loss of Ptc could trigger medulloblastoma in
postnatal GNPs, we treated Math1-creER/PtcC/C mice with ta-
moxifen at P4 and then examined mice at several time points
for changes in cerebellar structure. As with embryonic deletion,
postnatal deletion of Ptc resulted in increased GNP proliferation
and expansion of the EGL by P21 (Figure S5A). GNP proliferation
persisted into adulthood, but the majority of Ptc-deficient GNPs
differentiated and migrated into the IGL, leaving only discrete
foci of proliferating cells on the surface of the cerebellum
(Figure S5B). By 12 weeks of age, someMath1-creER/PtcC/C an-
imals began to exhibit symptoms of intracranial pressure, and by
19 weeks, all of these mice developed cerebellar tumors (Figures
4D–4F). Tumors were also observed in mice treated with tamox-
ifen at P8 and P10, but not in animals treated at P12 or later
(Table S1). These data indicate that both embryonic and postna-
tal GNPs can serve as cells of origin for medulloblastoma.
hGFAP-cre/PtcC/C Mice Allow Deletion of Ptc in Neural
Stem Cells
Having observed that deletion of Ptc in GNPs could cause me-
dulloblastoma, we wondered whether deletion in NSCs would
have the same effect. On one hand, since NSCs give rise to
GNPs, loss of Ptc in these cells might also be expected to result
in medulloblastoma. On the other hand, NSCs can also give rise
to other types of neurons and glia, so loss of Ptc in these cells
could potentially lead to other tumor types, such as astrocytoma
or oligodendroglioma. To delete Ptc in NSCs, we used hGFAP-
cre mice, in which expression of Cre is controlled by the human
glial fibrillary acidic protein (hGFAP) promoter (Zhuo et al., 2001).
Figure 4. Ptc Deletion in GNPs Leads to Medulloblastoma
(A–C) By 10 weeks of age, most Math1-cre/PtcC/C mice develop tumors.
(A) Cerebellum containing tumor.
(B) H&E-stained section of tumor.
(C) H&E-stained section of secondary tumor, induced by transplantation of
Math1-cre/PtcC/C tumor cells into cerebellum of adult SCID/beige mouse.
(D and E) Postnatal deletion of Ptc in GNPs results in medulloblastoma.
Math1-creER/PtcC/C mice were treated with tamoxifen at P4 and sacrificed
when symptoms developed (in this case, at 17 weeks). Cerebella were photo-
graphed intact (D) or sectioned and stained with H&E (E).
(F) Survival curves for Math1-cre/PtcC/C mice (red) and Math1-creER/PtcC/C
mice treated with tamoxifen at P4 (blue).
Scale bars: 3 mm in (A), (B), (D), and (E); 400 mm in (C).Whereas the Math1 enhancer drives expression in progenitors
after they have left the ventricular zone (VZ) and committed to
the granule cell lineage (or are destined for the DCN or brain-
stem), the hGFAP promoter turns on prior to lineage commitment
in VZ progenitors that give rise to granule neurons as well as
most other types of neurons and glia in the cerebellar cortex
(Casper and McCarthy, 2006; Zhuo et al., 2001).
To confirm the specificity of the hGFAP-cre transgene, we
stained sections from hGFAP-cre mice with anti-Cre antibodies
at various stages of development and examined expression of
GFP in hGFAP-cre/R26R-GFP reporter mice. These studies re-
vealed Cre protein expression predominantly in the VZ and in as-
troglial cells within the cerebellar parenchyma (Figure 5A); no Cre
expression was observed in the EGL or in cells expressingMath1
(Figures S1G–S1L; Figure S6). Nonetheless, analysis of GFP ex-
pression in hGFAP-cre/R26R-GFP mice indicated that Cre-
expressing cells gave rise to granule neurons as well as basket
and stellate neurons, Bergmann glia, and oligodendrocytes (Fig-
ures 5B–5F; Figure S3B), suggesting that the hGFAP+ population
included multipotent stem cells. Consistent with previous re-
ports (Spassky et al., 2008; Zhuo et al., 2001), no labeling of Pur-
kinje cells was observed, suggesting that these cells arise from
a distinct pool of (hGFAP) NSCs or are generated at a stage
of development prior to expression of the hGFAP promoter
(Hashimoto and Mikoshiba, 2003).
To confirm that the hGFAP promoter is expressed in stem
cells, we also isolated GFP+ cells from E14.5 hGFAP-GFP
cerebella (Zhuo et al., 1997) and tested their ability to form neuro-
spheres. FACS-sorted hGFAP-GFP+ cells generated neuro-
spheres when cultured at clonal density in the presence of
growth factors, and individual clones were able to differentiate
into neurons, astrocytes, and oligodendrocytes when growth
factors were withdrawn (Figure S7). Neurospheres also formed
from hGFAP-GFP cells (albeit with 10-fold lower efficiency),
suggesting that a subpopulation of embryonic cerebellar stem
cells do not express hGFAP. These studies indicate that the
hGFAP promoter is expressed in the majority of NSCs in the em-
bryonic cerebellum and that it can be used to target cells at an
earlier stage of differentiation than the Math1 enhancer.
Deletion ofPtc in StemCells Results inMedulloblastoma
To examine the consequences of Ptc deletion in hGFAP-
expressing cells, we crossed the hGFAP-cre mice with PtcC/C
mice and analyzed progeny during embryonic and postnatal de-
velopment. Between E14.5 and E16.5, hGFAP-cre/PtcC/C mice
showed expansion of the VZ, accompanied by increased prolif-
eration and increased expression of group B1 Sox proteins,
markers of multipotent stem cells (Figures 6A–6D) (Pevny and
Placzek, 2005; Tanaka et al., 2004). Consistent with this, cere-
bellar cells from hGFAP-cre/PtcC/C mice generated an increased
number of neurospheres compared to WT mice (Figure 6E).
These neurospheres were able to differentiate into neurons, as-
trocytes, and oligodendrocytes (Figure S8). Increased neuro-
sphere formation was also observed in PtcC/C cells infected
with cre-encoding retroviruses in vitro (Figure 6F). Together,
these data suggest that hGFAP-cre-mediated deletion of Ptc
results in increased proliferation of NSCs.
During development, NSCs give rise to astrocytes, oligodendro-
cytes, and several types of neurons. In the hGFAP-cre/PtcC/CCancer Cell 14, 135–145, August 12, 2008 ª2008 Elsevier Inc. 139
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Cell of Origin for Ptc-Associated MedulloblastomaFigure 5. hGFAP-cre Mice Express Cre Protein in
Neural Stem Cells
(A) Cerebellar sections from E16.5 hGFAP-cre mice were
stained with anti-Cre antibodies (red) and counterstained
with DAPI (blue). Note the expression of Cre in the ventricular
zone (VZ) but not in the EGL.
(B–F) Cerebellar sections from P8 hGFAP-cre/R26R-GFP mice
were stained with anti-GFP antibodies (green) to detect cells
that had expressed Cre at some stage of development and
with antibodies specific for Ki67 to detect proliferating GNPs
(B), NeuN to detect postmitotic granule neurons (C), Pax2 to la-
bel interneuron progenitors (D), BLBP to label Bergmann glia
(bg) and astrocytes (E), or O4 to detect oligodendrocytes in
the white matter (WM) (F). GFP was found to be coexpressed
with each of these cell types (yellowstaining). Scalebars:25mm.mice, these cells should all lack Ptc, since they arise from Ptc-
deficient NSCs. Despite this, no obvious abnormalities were
seen in astrocytes, oligodendrocytes, or non-granule neurons
of hGFAP-cre/PtcC/C mice (data not shown). In contrast, marked
Figure 6. hGFAP-cre-Mediated Deletion of Ptc Leads to Expansion
of NSCs
(A–D) hGFAP-cre (A and C) and hGFAP-cre/PtcC/C (B and D) embryos were
pulsed with BrdU 2 hr before being sacrificed at E14.5. Brains were harvested,
and cerebellar sections were stained with anti-BrdU (A and B) or anti-group B1
Sox (C and D) antibodies. Cerebella from hGFAP-cre/PtcC/C mice contained
significantly more BrdU+ and SoxB1+ cells in the ventricular zone (VZ). Scale
bars: 20 mm.
(E and F) Deletion ofPtc in embryonic cerebellar cells promotes increased neu-
rosphere formation. Data represent means of triplicate samples ± SEM.
(E) Cerebella from E14.5 PtcC/C and hGFAP-cre/PtcC/C embryos were dissoci-
ated, and cells were cultured at clonal density in neurosphere medium. The
number of neurospheres per mouse was calculated by multiplying the number
of cells obtained from each embryo by the number of neurospheres observed
in cultures from that embryo. Cerebella from hGFAP-cre/PtcC/C mice yielded
2.7 times more neurospheres than those from PtcC/C mice.
(F) Cells isolated from E14.5 PtcC/C embryos were infected with no virus or with
viruses carrying GFP or cre-IRES-GFP. Infected (GFP+) cells were sorted and
cultured at clonal density in neurosphere medium. After 7 days, cre virus-in-
fected cells generated 2.8 times more neurospheres than GFP-infected cells
and noninfected cells.140 Cancer Cell 14, 135–145, August 12, 2008 ª2008 Elsevier Inc.changes were seen in VZ-derived cells that migrated to the
rhombic lip and committed to the granule lineage. hGFAP-cre/
PtcC/C mice exhibited a dramatic expansion of the rhombic lip
and EGL at E16.5 (Figures 7A and 7B). After birth, when the
WT cerebellum contained only one to two rows of GNPs on its
surface, the hGFAP-cre/PtcC/C cerebellum was encompassed
by a thick, disorganized EGL (Figures 7C and 7D). Analysis of ge-
nomic Ptc from the postnatal EGL confirmed that there was near
complete (>90%) deletion of Ptc at this stage (Figures S3C and
S3D). By P14, the entire cerebellum was filled with GNP-like
cells, and animals began to show symptoms of illness (Figures
7E and 7F). By 4 weeks, all hGFAP-cre/PtcC/C mice developed
cerebellar tumors and were sacrificed (Figures 7G–7I). These
data show that tumors can be induced by deletion of Ptc in multi-
potent progenitors as well as in lineage-restricted GNPs.
Interestingly, tumors in Math1-cre/PtcC/C mice and hGFAP-
cre/PtcC/C mice expressed abundant and comparable levels of
the GNP markerMath1 and the proliferation marker Ki67 (Figures
8A–8D). In regions of differentiation, most cells expressed the
neuronal differentiation markers NeuN, synaptophysin, and GA-
BRA6 (Figures 8E and 8F; data not shown). Few tumor cells in ei-
ther strain expressed markers of neural stem cells, non-granule
neurons, or glia, and cells that did express these markers were
almost never proliferative (Figures 8G–8J). Tumor cells from
hGFAP-cre/PtcC/C mice and Math1-cre/PtcC/C mice also ex-
hibited similar levels of proliferation (Figure 8K) and induced tu-
mors with similar efficiency and latency following transplantation
of 0.05–1.0 3 106 tumor cells into immunodeficient hosts
(Figure 8L; data not shown). These observations indicate that tu-
mors initiated in stem cells and progenitors are remarkably sim-
ilar. The dramatic expansion of the EGL in neonatal hGFAP-cre/
PtcC/C mice and the predominant expression of GNP markers in
tumors from both strains suggest that tumor formation in these
animals is restricted to the granule lineage. Thus, medulloblas-
toma can be initiated by deletion of Ptc in multipotent stem cells
or lineage-restricted progenitors, but the oncogenic effects of
Shh signaling are only manifest once cells have committed to
the granule lineage.
DISCUSSION
The origin of medulloblastoma has been the subject of contro-
versy for many years (Eberhart, 2007; Read et al., 2006). Al-
though some investigators have speculated that these tumors
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Cell of Origin for Ptc-Associated Medulloblastomaarise from GNPs, the evidence has been largely circumstantial:
the morphology of tumor cells, the location of these cells on
the surface of the cerebellum (where GNPs develop), and the ex-
pression of GNP-associated markers. The fact that Shh is mito-
genic for GNPs (Wechsler-Reya and Scott, 1999) and the obser-
vation that medulloblastomas in Ptc+/ mice resemble GNPs
(Goodrich et al., 1997; Oliver et al., 2005) have suggested that
Ptc-associated tumors in particular might be derived from these
cells. However, the recent observations that Shh is required for
stem cell growth and maintenance (Ahn and Joyner, 2005; Ba-
lordi and Fishell, 2007) and that medulloblastomas often express
Figure 7. Deletion of Ptc in NSCs Results in Rapid Tumor Formation
(A–H) Cerebellar sections from PtcC/C (A, C, E, and G) and hGFAP-cre/PtcC/C
(B, D, F, and H) mice were harvested and stained with H&E (A–F) or photo-
graphed whole-mount (G and H) at E16.5–P21. Note the expansion of both
the VZ and EGL at E16.5 (A and B) and the persistent expansion of the EGL
at postnatal ages (C–F). The arrow in (H) points to a tumor that has formed
in the cerebellum. The forebrain (asterisk in H) in these animals also appears
enlarged; histological examination (not shown) indicates that this is due to
expansion of the ventricle (perhaps due to occlusion of cerebrospinal fluid
circulation) rather than to increased growth or tumorigenesis in the cortex.
(I) Survival curve for hGFAP-cre/PtcC/C mice.
Scale bars: 20 mm in (A) and (B); 100 mm in (C) and (D); 300 mm in (E) and (F); 2.5
mm in (G) and (H).stem cell markers (Hemmati et al., 2003; Singh et al., 2003) have
cast doubt on this view. By deleting Ptc in GNPs and in stem
cells, we provide direct evidence that each of these cells can
serve as a cell of origin for Shh pathway-associated medullo-
blastoma.
Figure 8. Tumors from Math1-cre/PtcC/C and hGFAP-cre/PtcC/C
Mice Display Similar Phenotypes
(A–J) Sections fromMath1-cre/PtcC/C (A, C, E, G, and I) and hGFAP-cre/PtcC/C
(B, D, F, H, and J) tumors were subjected to in situ hybridization to detect ex-
pression of Math1 (A and B) or stained with antibodies to detect proliferating
cells (Ki67; C, D, G, H, I, and J), differentiating neurons (NeuN; E and F), astro-
cytes (S100; G and H), and stem cells (Sox2; I and J). Sections in (C)–(F) were
counterstained with DAPI (blue). In (A) and (B), asterisk denotes tumor and
‘‘bs’’ indicates brainstem. Scale bars: 25 mm.
(K) Tumor cells were cultured for 48 hr, pulsed with tritiated thymidine (3H-Td),
and harvested 18 hr later for measurement of thymidine incorporation. Data
represent means of triplicate samples ± SEM.
(L) Survival curves of SCID/beige mice after transplantation of 1 3 106 tumor
cells isolated from hGFAP-cre/PtcC/C mice, Math1-cre/PtcC/C mice, and
Math1-creER/PtcC/C mice that had been treated with tamoxifen at P4.Cancer Cell 14, 135–145, August 12, 2008 ª2008 Elsevier Inc. 141
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Cell of Origin for Ptc-Associated MedulloblastomaTumorigenesis is thought to depend on a capacity for long-
term self-renewal. During normal development, GNPs do not ex-
hibit this capacity: they proliferate for 2–3 weeks after birth and
then exit the cell cycle and undergo terminal differentiation.
The fact that GNPs in Math1-cre/PtcC/C mice continue to prolif-
erate into adulthood (and continue to divide following transplan-
tation) suggests that loss ofPtc can increase the self-renewal ca-
pacity of these cells. Thus, while neural stem cells—which are
thought to have an intrinsic capacity for long-term self-re-
newal—might represent a good target for oncogenic transforma-
tion, restricted progenitors can also become transformed if,
through mutation, they acquire the capacity for long-term self-
renewal. The ability of oncogenic mutations to increase the
self-renewal capacity of lineage-restricted progenitors has also
been demonstrated in the hematopoietic system (Cozzio et al.,
2003; Krivtsov et al., 2006).
Our studies show that deletion of Ptc in GNPs promotes a dra-
matic increase in proliferation of these cells and results in tumors
in all mice. However, it is notable that in Math1-cre/PtcC/C and
Math1-creER/PtcC/C mice, many GNPs are able to differentiate
despite loss of Ptc, and only a subset of cells continues to pro-
liferate and forms tumors. One explanation for this is that full
transformation of GNPs requires changes besides loss of Ptc,
and these changes only occur in a subset of GNPs. This notion
is supported by our studies of conventional Ptc+/ mice (Oliver
et al., 2005), which demonstrated that loss of Ptc results in pre-
neoplastic lesions but that most of these lesions do not go on to
become tumors. Expression profiling of GNPs, preneoplastic
cells, and tumor cells suggested that altered expression of genes
involved in cell migration, differentiation, or apoptosis might be
necessary for complete transformation.
In addition to GNPs, NSCs can also give rise to tumors follow-
ing deletion of Ptc. Loss of Ptc in NSCs initially results in expan-
sion of the VZ and increased numbers of stem cells. Our dem-
onstration that Ptc deletion causes proliferation of cerebellar
stem cells is consistent with previous reports showing a role
for Shh in stem cell renewal in other parts of the central nervous
system (Ahn and Joyner, 2005; Balordi and Fishell, 2007). Im-
portantly, while Ptc-deficient NSCs exhibit increased prolif-
eration, they remain capable of differentiating into astrocytes,
oligodendrocytes, and neurons. Indeed, the most dramatic con-
sequences of Ptc deletion occur once cells leave the VZ and
commit to the granule cell lineage. GNPs in hGFAP-cre/PtcC/C
mice undergo rapid expansion, encompass the cerebellum at
early postnatal stages, and appear to give rise to medulloblas-
tomas in these mice. Support for this notion comes from the fact
that the majority of cells in hGFAP-cre/PtcC/C tumors (like those
in Math1-cre/PtcC/C tumors) express GNP markers rather than
NSC markers. Moreover, the differentiated cells present within
these tumors predominantly express markers of postmitotic
granule neurons (NeuN, GABRA6) rather than non-granule neu-
rons, astrocytes, or oligodendrocytes, as would be expected if
tumors retained characteristics of multipotent stem cells. The
fact that deletion of Ptc in NSCs does not lead to other tumor
types (e.g., astrocytomas, oligodendrogliomas, or even medul-
loblastomas with non-GNP characteristics) is remarkable and
suggests that the granule lineage may be exquisitely sensitive
to the oncogenic effects of hedgehog signaling. Alternatively,
it is possible that additional genetic or epigenetic events142 Cancer Cell 14, 135–145, August 12, 2008 ª2008 Elsevier Inc.(besides loss of Ptc) are needed for tumor formation and that
these are most likely to occur during the rapid expansion of
GNPs in the EGL.
While our data suggest that deletion of Ptc in hGFAP-ex-
pressing NSCs does not result in glial tumors, this does not
mean that Shh signaling does not play any role in initiation or
maintenance of such tumors. For example, it is possible that ac-
tivation of the hedgehog pathway in distinct progenitors, or in
combination with additional oncogenic lesions, might result in
formation of astrocytomas or oligodendrogliomas. Moreover,
recent studies have suggested that the Shh pathway is active
in human glioma and in mouse models of the disease (Becher
et al., 2008; Clement et al., 2007; Ehtesham et al., 2007) and
that treatment with Shh pathway inhibitors can suppress the
growth of glioma cell lines and xenografts (Bar et al., 2007;
Clement et al., 2007). These data raise the possibility that Shh
signaling, even if it is not involved in tumor initiation, might con-
tribute to tumor growth or maintenance. Further studies of Shh
pathway antagonists in transgenic and xenograft models of
glioma will be required to determine the importance of this
pathway as a therapeutic target.
In the discussion above, we refer to the tumors in hGFAP-
cre/PtcC/C mice as being ‘‘initiated’’ in NSCs. Since these tu-
mors do not manifest until cells have committed to the granule
lineage, it is reasonable to ask whether they should be more
aptly considered to be initiated in GNPs. In this context, we be-
lieve it is important to draw a distinction between tumor initia-
tion and transformation. We consider tumor initiation to be
the stage at which the first oncogenic mutation occurs, even
if this mutation is not sufficient to fully transform the cell. In con-
trast, we view transformation as the stage at which cells have
accumulated all of the oncogenic mutations that they need to
form tumors. With this framework in mind, we believe it is ap-
propriate to refer to tumors in hGFAP-cre/PtcC/C mice as initi-
ated in stem cells and to consider NSCs as the cells of origin
for these tumors.
In comparing tumors in hGFAP-cre/PtcC/C and Math1-cre/
PtcC/C mice, the only marked difference we observed was in
tumor latency: hGFAP-cre/PtcC/C mice developed tumors be-
tween 3 and 4 weeks of age, whereasMath1-cre/PtcC/C mice de-
veloped tumors between 8 and 12 weeks of age. One possible
explanation for the rapid expansion of tumors in hGFAP-cre/
PtcC/C mice is that deletion of Ptc in these animals is more effi-
cient than in Math1-cre/PtcC/C mice and that, as a result, there
are more Ptc-deficient GNPs to serve as a source for the tumors.
However, our analysis suggests that Cre activity (based on in-
duction of GFP inR26R reporter mice) andPtc deletion efficiency
(based on analysis of genomic Ptc levels) are very similar be-
tween the two strains. Another possible explanation for the dif-
ference in latency is that hGFAP-cre/PtcC/C tumor cells have
an increased rate of proliferation or a decreased rate of apopto-
sis and as a result give rise to more rapidly growing tumors. How-
ever, comparison of thymidine incorporation, cell-cycle analysis,
caspase activation, and even gene expression did not reveal any
significant differences in these parameters between hGFAP-cre/
PtcC/C and Math1-cre/PtcC/C tumor cells (Figure 8; unpublished
data). Moreover, transplantation of equal numbers of hGFAP-
cre/PtcC/C and Math1-cre/PtcC/C tumor cells into immunocom-
promised mice results in similar tumor latency in recipients.
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Math1-cre/PtcC/C tumor cells are also not likely to account for
the differences in age of tumor onset.
Instead, the differences in tumor latency are most likely a con-
sequence of the stage at which Ptc deletion occurs. Deletion of
Ptc in the VZ (using hGFAP-cremice) leads to an early expansion
of the stem cell pool. A larger stem cell pool leads, in turn, to a sig-
nificant increase in the starting number of GNPs, which then con-
tinue to expand and ultimately contribute to tumor bulk. Since
animals develop symptoms when tumors reach a critical mass,
having a larger pool of Ptc-deficient GNPs at the outset allows
hGFAP-cre/PtcC/C mice to reach this stage much more quickly
than Math1-cre/PtcC/C mice. This model may also explain the
shorter latency of tumors in Math1-cre/PtcC/C mice compared
toMath1-creER/PtcC/C mice that are exposed to tamoxifen post-
natally: whereas embryonic deletion of Ptc targets all GNPs,
postnatal deletion targets only the subset of GNPs that have
not yet differentiated. As a result, it takes GNPs in postnatally tar-
geted animals longer to reach critical mass. The same may be
true for tumors in other tissues: the earlier in a given lineage
that an oncogenic mutation occurs, the more opportunity there
is for expansion of cells bearing this mutation, and the more
dramatic the consequences for the animal.
These observations may have particular significance for hu-
man medulloblastoma. Although medulloblastoma can occur in
children as well as adults, patients who develop tumors at
a very young age (<3 years) have a high risk for treatment failure
and relapse, while those who develop the disease when they are
older tend to have a more favorable outcome (Kalifa and Grill,
2005). One reason for this may be that radiation therapy, which
is commonly used in older patients, is withheld from young chil-
dren because it is considered to be too damaging for the devel-
oping brain. Thus, tumors in young children may grow faster be-
cause they are treated less aggressively. However, our findings
suggest that the cell in which the tumor is initiated may also
contribute to the age of onset and the difference in prognosis: tu-
mors that occur in young children may arise from mutations in
multipotent stem cells, whereas those in older children may orig-
inate from more differentiated progenitors. In the former case, as
in our hGFAP-cre/PtcC/C mice, expansion of stem cells and in-
creased production of GNPs may contribute to more rapid tumor
growth and earlier onset of symptoms.
Identifying the cell of origin for medulloblastoma may also
have important implications for therapy. Recent studies have
shown that many brain tumors contain NSC-like cells and have
suggested that these cells are important for tumor propagation
(Hemmati et al., 2003; Singh et al., 2004). In light of this, many in-
vestigators have begun to develop targeted therapies to eradi-
cate such cells. Our studies demonstrate that not all brain tumors
are derived from cells with a stem cell phenotype. In particular,
we show that Shh pathway-associated medulloblastomas may
be initiated in either progenitors or stem cells and ultimately
adopt a phenotype that resembles GNPs rather than NSCs.
Whether the same is true for other subtypes of medulloblastoma
remains to be investigated. Determining whether a tumor is de-
rived from lineage-restricted progenitors or stem cells, finding
markers specific for these cells, and identifying signals that con-
trol their growth and differentiation may be important prerequi-
sites for effective therapy.EXPERIMENTAL PROCEDURES
Mice
PtcC/C mice and Math1-creER mice have been described previously (Ellis
et al., 2003; Machold and Fishell, 2005). hGFAP-GFP mice (Zhuo et al.,
1997), hGFAP-cre mice (Zhuo et al., 2001), and R26R-GFP reporter mice
(Mao et al., 2001) were from The Jackson Laboratory. SCID/beige mice were
from Charles River Laboratories. Animals were maintained in the Cancer Cen-
ter Isolation Facility at Duke University, and all experiments were performed in
accordance with procedures approved by the Duke University Animal Care
and Use Committee.
Histology and Immunohistochemistry
For histological analysis, animals were perfused with PBS followed by 4%
paraformaldehyde (PFA). Cerebella were removed, fixed in 4% PFA overnight,
transferred to 70% ethanol and embedded in paraffin. Sections (5 mm) were
stained with hematoxylin and eosin (Sigma) or with anti-BrdU or anti-group
B1 Sox antibodies (Tanaka et al., 2004).
For immunohistochemistry, cerebella from PFA-perfused animals were
fixed overnight in 4% PFA, cryoprotected in 30% sucrose, frozen in Tissue
Tek-OCT (Sakura Finetek), and cut into 10–12 mm sagittal sections. Sections
were blocked and permeabilized for 2 hr with PBS containing 0.1% Triton
X-100 and 1% normal goat serum, stained with primary antibodies overnight
at 4C, and incubated with secondary antibodies for 2 hr at room temperature.
Sections were counterstained with DAPI and mounted with Fluoromount-G
(Southern Biotech) before being visualized using a Nikon TE200 microscope.
Antibodies used for immunostaining are listed in Supplemental Experimental
Procedures.
Cell Isolation and Proliferation Assays
Cerebella from P6 mice were digested with 10 U/ml papain (Worthington Bio-
chemical), 200 mg/ml L-cysteine, and 250 U/ml DNase (Sigma); triturated to
obtain a single-cell suspension; and then centrifuged through a 35%–65%
Percoll gradient (Sigma). Cells from the 35%–65% interface were suspended
in NB-B27 (Neurobasal with 1 mM sodium pyruvate, 2 mM L-glutamine, pen-
icillin/streptomycin, and B27 supplement, all from Invitrogen) and transferred
to poly-D-lysine-coated 96-well plates at a density of 23 105 cells per well. Af-
ter 48 hr, cells were pulsed with [methyl-3H]thymidine (Amersham/GE Health-
care) and cultured for an additional 16–18 hr. Cells were harvested onto filters
using a Mach IIIM Manual Harvester 96 (Tomtec), and incorporated radioac-
tivity was quantified by liquid scintillation spectrophotometry on a Wallac
MicroBeta scintillation counter (PerkinElmer).
Laser Capture Microdissection and Real-Time RT-PCR
Cerebella were removed immediately and frozen in OCT. Sagittal sections
(5 mm) were mounted onto glass slides, fixed in 75% ethanol for 30 s, and
stained with cresyl violet (Ambion). After 5 min of air drying, microdissection
was carried out using a PixCell IIe LCM system (Arcturus Bioscience). RNA
was extracted from LCM caps using an RNA isolation kit (Arcturus Bioscience).
For real-time RT-PCR, first-strand cDNA was synthesized from equal amounts
of RNA (0.1–1 mg) using SuperScript III Reverse Transcriptase (Invitrogen).
Triplicate reactions were prepared using a 25 ml mixture containing iQ SYBR
Green Supermix (Bio-Rad). Real-time quantification was performed on
a Bio-Rad iCycler iQ system. Serial 10-fold dilutions of cDNA were used as
references for the standard curve. Raw data were normalized based on ex-
pression of actin. Primers used for Gli1, N-myc, Cyclin D1, and Ptc are listed
in Supplemental Experimental Procedures.
Intracranial Transplantation
SCID/beige mice (6–8 weeks old) were anesthetized with xylazine (25 mg/kg,
Lloyd Laboratories) and ketamine (125 mg/kg, Fort Dodge Animal Health) and
placed in a stereotaxic apparatus (David Kopf Instruments). After exposing the
skull with a scalpel, a 1 mm diameter hole was drilled in the skull over the cer-
ebellum using an 18G needle. A cell suspension (13 106 cells in 5 ml NB-B27)
was slowly injected into the cerebellum at a depth of 1 mm using a 5 ml Ham-
ilton syringe with an unbeveled 24G needle. After injection, the incision was
sutured using catgut sutures (Johnson & Johnson).Cancer Cell 14, 135–145, August 12, 2008 ª2008 Elsevier Inc. 143
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Tamoxifen (T5648, Sigma) was prepared as a 20 mg/ml stock solution in corn
oil (Sigma). Tamoxifen was administered by oral gavage using 24G gavaging
needles (Fine Science Tools). Tamoxifen doses were 0.6 mg/30 ml at P4,
1 mg/50 ml at P8, 1.4 mg/70 ml at P10, 1.6 mg/80 ml at P12, and 4.0 mg/200ml
for treatment of pregnant females.
Neurosphere Cultures
To generate primary neurospheres, cells from E14.5 embryonic cerebella were
plated at 2 3 105 cells/ml in NSC proliferation medium (NeuroCult basal me-
dium with proliferation supplement, Stem Cell Technologies) plus 10 ng/ml ba-
sic fibroblast growth factor and 20 ng/ml epidermal growth factor (PeproTech).
Neurospheres were counted or harvested for immunostaining after 7 days in
culture. For self-renewal assays, neurospheres were mechanically dissociated
and replated in fresh proliferation medium at 2 3 103 cells/ml. For differentia-
tion assays, neurospheres were plated on poly-D-lysine-coated coverslips
(BD Biosciences) in NSC differentiation medium (NeuroCult basal medium
with differentiation supplement). Seven days after plating, cultures were fixed
with 4% PFA for immunostaining.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, one
table, and eight figures and can be found with this article online at http://
www.cancercell.org/cgi/content/full/14/2/135/DC1/.
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